GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (OTCPK:TSMRF) » Definitions » Cyclically Adjusted Price-to-FCF

Tsumura (Tsumura) Cyclically Adjusted Price-to-FCF : 68.62 (As of Jun. 08, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Tsumura Cyclically Adjusted Price-to-FCF?

As of today (2024-06-08), Tsumura's current share price is $26.76. Tsumura's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.39. Tsumura's Cyclically Adjusted Price-to-FCF for today is 68.62.

The historical rank and industry rank for Tsumura's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

TSMRF' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 36.27   Med: 50.34   Max: 76.92
Current: 69.18

During the past years, Tsumura's highest Cyclically Adjusted Price-to-FCF was 76.92. The lowest was 36.27. And the median was 50.34.

TSMRF's Cyclically Adjusted Price-to-FCF is ranked worse than
74.53% of 322 companies
in the Drug Manufacturers industry
Industry Median: 31.865 vs TSMRF: 69.18

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Tsumura's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $-0.044. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.39 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tsumura Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Tsumura's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsumura Cyclically Adjusted Price-to-FCF Chart

Tsumura Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.82 68.09 43.80 36.77 66.61

Tsumura Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.77 41.95 43.56 47.25 66.61

Competitive Comparison of Tsumura's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Tsumura's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tsumura's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tsumura's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Tsumura's Cyclically Adjusted Price-to-FCF falls into.



Tsumura Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Tsumura's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=26.76/0.39
=68.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tsumura's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Tsumura's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.044/107.2000*107.2000
=-0.044

Current CPI (Mar. 2024) = 107.2000.

Tsumura Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.136 98.000 0.149
201409 -0.460 98.500 -0.501
201412 -0.116 97.900 -0.127
201503 -0.141 97.900 -0.154
201506 0.808 98.400 0.880
201509 -0.177 98.500 -0.193
201512 -0.062 98.100 -0.068
201603 0.605 97.900 0.662
201606 0.190 98.100 0.208
201609 1.007 98.000 1.102
201612 -0.031 98.400 -0.034
201703 0.564 98.100 0.616
201706 0.974 98.500 1.060
201709 -0.060 98.800 -0.065
201712 -0.124 99.400 -0.134
201803 0.539 99.200 0.582
201806 0.488 99.200 0.527
201809 -0.685 99.900 -0.735
201812 -0.407 99.700 -0.438
201903 0.208 99.700 0.224
201906 0.335 99.800 0.360
201909 -0.058 100.100 -0.062
201912 -0.070 100.500 -0.075
202003 0.722 100.300 0.772
202006 0.590 99.900 0.633
202009 0.202 99.900 0.217
202012 -0.067 99.300 -0.072
202103 0.088 99.900 0.094
202106 0.046 99.500 0.050
202109 0.764 100.100 0.818
202112 0.263 100.100 0.282
202203 0.178 101.100 0.189
202206 0.087 101.800 0.092
202209 0.094 103.100 0.098
202212 -0.469 104.100 -0.483
202303 0.458 104.400 0.470
202306 -0.445 105.200 -0.453
202309 -0.327 106.200 -0.330
202312 -0.499 106.800 -0.501
202403 -0.044 107.200 -0.044

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tsumura  (OTCPK:TSMRF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Tsumura Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Tsumura's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsumura (Tsumura) Business Description

Industry
Traded in Other Exchanges
Address
2-17-11, Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Tsumura (Tsumura) Headlines

From GuruFocus

Q2 2020 Tsumura & Co Earnings Presentation Transcript

By GuruFocus Research 02-15-2024